ArticleEuropean journal of clinical pharmacology2018

CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients.

Daohua Shi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.